“…Genetic variation in the Dlg2 gene, which encodes the membrane associated guanylate kinase (MAGUK) synaptic scaffolding protein PSD93, also known as Dlg2 or chapsyn‐110, has been associated with an array of psychiatric disorders 1 including schizophrenia, 2 intellectual disability, 3 bipolar disorder, 4 autism spectrum disorder, 5 attention deficit hyperactivity disorder, 6 and pubertal disorders. 7 , 8 The PSD93 protein is expressed widely throughout the brain 9 , 10 , 11 and has been demonstrated to interact with a variety of other proteins in the postsynaptic density, including NMDAR receptor subunits, 12 , 13 , 14 , 15 , 16 AMPAR auxiliary subunit stargazin, 17 potassium channels, 18 , 19 , 20 , 21 and other cytoskeletal components. 12 , 22 , 23 , 24 , 25 , 26 Work on homozygous knockout rodents models of Dlg2−/− has found evidence of deficits in glutamatergic signalling, 10 , 14 , 27 , 28 , 29 , 30 , 31 plasticity, 28 and dendritic 32 and spine 31 morphology in the hippocampus, dorsal striatum, spinal dorsal horn, and cingular and visual cortices.…”